RT @KDAO2011: Study of IV tocilizumab for GCA that led to FDA approval of intravenous TCZ this year (2/2022) -one of Dr
Tweet Content
Study of IV tocilizumab for GCA that led to FDA approval of intravenous TCZ this year (2/2022) -one of Dr. C Langford's pick for #YearinReview
@rheumnow #ACR22 https://t.co/luxDDluddM
Links
Effect of Tocilizumab on Disease Activity in Patients With Active Polymyalgia R…
https://jamanetwork.com/journals/jama/fullarticle/2796378
Show on Archive Page
On
Display in Search Results
On
PDQ
Off